Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Oncology155.2M30.37%
Other108.4M21.21%
Metabolic103.64M20.28%
Cardiology55.64M10.89%
Central Nervous System44.14M8.64%
Antiviral and Anti-infective (AVAI)44.03M8.62%
View all
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States1.85B98.00%
North America, Europe, Asia, South America, Africa and Australia37.72M2.00%
